base editing
A precise gene-editing technique that changes individual DNA letters (nucleotides) without cutting both strands of the double helix.
As defined in 394 - Bringing Back The Mammoth
Where it comes up · 4
- Investing in Healthcare2 claims
- 394 - Bringing Back The Mammoth2 claims
- Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]2 claims
- 357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics2 claims
Most important claims · 8 of 8Search all claims for “base editing” →
- KJ Muldoon, born with CPS1 deficiency that affects roughly 1 in 1.3 million children and causes toxic ammonia buildup, was treated at Children's Hospital of Philadelphia with a personalized mRNA-delivered base editor given in three doses, with FDA approval within weeks, and now no longer needs a liver transplant, though he is not cured.357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics
- De-extinction would not have been a viable undertaking before roughly 2012-2015, when reliable CRISPR-based targeting and repair emerged, followed by base and prime editing; even now it requires substantial compute and AI, and the field is only in the right five-year window to truly deliver results.394 - Bringing Back The Mammoth
- Colossal uses a combination of editing tools—single-nucleotide base edits, gene knockouts, and synthesizing and inserting large DNA blocks to reduce off-target effects—but its key differentiator is pioneering multiplex editing, making many edits (20, 50, a thousand) across the genome simultaneously with high efficiency, since whole-chromosome synthesis is not yet possible.394 - Bringing Back The Mammoth
- CRISPR is already becoming dated because base editors change specific DNA letters without making double-strand cuts, and prime editing may follow with even more versatile edits, making them more precise than cut-based CRISPR for certain genetic diseases.Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]
- Beam Therapeutics' base editing, a next-generation CRISPR, does not cut both DNA strands as CRISPR does; instead it latches onto a specified genome location and enzymatically converts a single DNA letter into another, a lighter-touch fix for single point mutations.Investing in Healthcare
- Combining CRISPR targeting with base editing and encoding the editor as mRNA allows an in vivo correction of a single DNA letter; because the mRNA is then destroyed, the editing machinery does not persist and cannot wander to cause off-target changes.357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics
- The development of many distinct biotech treatment modalities, including CRISPR, RNA interference, CAR T-cells, and base editing, is Alex's most exciting development, because humans increasingly control biological systems with precise molecular tools.Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]
- Beam Therapeutics, a company D.A. backed a couple of years earlier, recently IPO'd, is co-founded by some of the inventors of CRISPR and develops base editing as a next-generation alternative.Investing in Healthcare